4,453,688 Hits in 7.6 sec

Roper Center: Where are we now? Where are we going?

Tim Parsons
2020 Zenodo  
In this presentation, we will pull back the development curtain to describe the discovery process, explain our method for prioritizing tasks, review items completed and those we plan to execute, and conclude  ...  At IASSIST 2016, we reviewed the myriad of challenges behind maintaining uninterrupted service while migrating a 71-year-old archive from one location to another.  ...  Why are we doing this?  ... 
doi:10.5281/zenodo.3775615 fatcat:bitsd4uilzdqrdjh2l4f4os33a

Biomonitoring – where we are now and where we are going

Fucic A
2015 Biomonitoring  
We are moulding an approach to biomonitoring in which feelings of comfort or happiness, as an additionally recognized modifier of biological response, will very soon become an inevitable part of questionnaires  ...  We have to assert the role of visionaries and look to the future of biomonitoring, which will undoubtedly have significant importance in investigations of health risks during interplanetary voyages and  ... 
doi:10.1515/bimo-2015-0003 fatcat:xdczfo64pbclxfansadwao5vuu


Hiliary Monteith, Sharon Tan
2020 Turtle Island Journal of Indigenous Health  
The idea has since morphed into the establishment of a peer-reviewed journal and an accompanying Community of Practice (CoP) where people with an interest in Indigenous health can discuss, collaborate,  ...  EDITORIAL Where Are We Now, and Where Are We Going fo r I n d ig en ou s H e a l t h W a a k e b i n e ss -Br y c e I n s ti tu te ademia exacerbates the challenges that Indigenous and non-Indigenous scholars  ...  Where Are We Going TIJIH invites a variety of knowledges, including Indigenous arts-based knowledge.  ... 
doi:10.33137/tijih.v1i1.34914 fatcat:ytrdvfahhrcx5h5usfbvehvw4u

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?

Gordon A. McLorie
2008 Advances in Urology  
All of this literature leads us to the current era, when several clinical trials are currently underway in an effort to more fully define the most efficacious and safe methods to treat vesicoureteral reflux  ...  We have traced the original studies, coupled with advances in technology which led to the awareness, and ability to detect and diagnose the problems early in childhood.  ...  We now dwell in a world where we STILL question whether the reflux itself is the major problem, or just an easily diagnosed and treated cofactor.  ... 
doi:10.1155/2008/459630 pmid:18846239 pmcid:PMC2563150 fatcat:3p6d6ryrgrbk7ihsd56bzz4uza

Self-care research: Where are we now? Where are we going?

Barbara Riegel, Sandra B. Dunbar, Donna Fitzsimons, Kenneth E. Freedland, Christopher S. Lee, Sandy Middleton, Anna Stromberg, Ercole Vellone, David E. Webber, Tiny Jaarsma
2019 International Journal of Nursing Studies  
Beyond these specific short-term goals, important policy implications of this work are discussed.  ...  The vision of this Center is a world where self-care is prioritized by individuals, families, and communities and is the first line of approach in every health care encounter.  ...  We use these reflections as a basis for recommendations regarding next steps for self-care research. Background Where are we now?  ... 
doi:10.1016/j.ijnurstu.2019.103402 pmid:31630807 pmcid:PMC7035984 fatcat:empevdcvevgo7bh3ef342xq5fq

Mendelian randomization: where are we now and where are we going?

S. Burgess, N. J. Timpson, S. Ebrahim, G. Davey Smith
2015 International Journal of Epidemiology  
The origins of what is now termed "Mendelian randomization" (Figure 1 , see caption for assumptions) can be traced back over half a century 1 , although the first extended presentation of the principles  ...  technique of instrumental variables analysis central to Mendelian randomization was initially conceived 22 ) are being developed 23 24 .  ...  Mendelian randomization: where are we now and where are we going?  ... 
doi:10.1093/ije/dyv108 pmid:26085674 fatcat:cp3asfxtczbmxgdaua25mog7d4

Where Are We Now, and Where Are We Going? Perspectives on Cosmic Abundances [article]

Timothy C. Beers
2004 arXiv   pre-print
Secondly, now that these objects have been detected, new surveys can (and are) being carried out to find numerous additional examples of these phenomena. Where Are We Going?  ...  Where Are We Now? Before looking too far forward it is good to glance over our shoulders, and take note of how far we have come.  ... 
arXiv:astro-ph/0411751v1 fatcat:wvv7epo5vfc7bkpyuqpg45lckm

Myocardial T1 mapping: where are we now and where are we going?

James Moon, Amna Abdel-Gadir, Thomas Treibel
2014 Research Reports in Clinical Cardiology  
ECV mapping is now a reality, and new challenges are being considered, such as whole-heart and right ventricle coverage with higher spatial and temporal resolution, advanced image registration, and new  ...  Initially performed in myocardial infarction, LGE imaging is now recognized in most cardiac diseases.  ... 
doi:10.2147/rrcc.s50891 fatcat:w5zi5gpsmzcrrfpphhz57nsfja

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?

Albert Jang, David M. Adler, Grant P. Rauterkus, Mehmet A. Bilen, Pedro C. Barata
2021 Cancers  
Immune checkpoint inhibitors (ICIs) are now being used extensively to treat multiple solid tumors, including kidney and bladder cancers, and they are also being tested in many other cancers.  ...  Then, given the emergence of this class of agents, we summarize the several important ICIs and the clinical trials that led to their approval. Finally, we mention ongoing and future clinical trials.  ...  We summarize selected clinical trials that are complete, those that are still in progress, and those that are about to begin.  ... 
doi:10.3390/cancers13205065 pmid:34680214 fatcat:ajz2k64slvgtppi5w5jtlq4arq

Genetics of pancreatic cancer: where are we now? Where are we going?

Marco Del Chiaro, Ugo Boggi, Silvano Presciuttini, Laura Bertacca, Chiara Croce, Irene Mosca, Franco Mosca
2005 Journal of the Pancreas  
In addition, the diagnostic tools which are available to detect early pancreatic malignancies, such as dysplasia, are still limited.  ...  Mutations in the p-53 gene are described in about 75% of cases of pancreatic ductal carcinoma [6] , and are present in about 50% of all cancers.  ... 
pmid:15650288 fatcat:thioiuyj4ffbrmjpe3yan2tvhq

Introduction: The exegesis now: where are we, and where are we going?

Craig Batty and Donna Lee Brien
2017 Text: Journal of the Australian Association of Writing Programs  
So, where is the exegesis now?  ...  Collectively, therefore, these essays not only map the rich terrain upon which we currently operate in terms of the exegesis, but also propose and speculate about where we might go next, to further develop  ... 
doi:10.52086/001c.25859 fatcat:3kkuion4h5dlxj24bn3ted6dei

HIV prevention 2010: where are we now and where are we going?

Myron S Cohen, Sarah Fidler
2010 Current Opinion in HIV and AIDS  
Acknowledgement There are no conflicts of interest.  ...  HIV and syphilis among men who have sex with men in China: the time to act is now. Sex Transm Dis 2010. [Epub ahead of print] 5 Mayer KH, Mimiaga MJ, Safren SA.  ...  Model results are entirely determined by the assumptions employed and the math.  ... 
doi:10.1097/coh.0b013e32833acafa pmid:20539086 fatcat:l3r2zhvgefdolplr3y2c64fdfu

Diversity in organizations: Where are we now and where are we going?

Lynn M. Shore, Beth G. Chung-Herrera, Michelle A. Dean, Karen Holcombe Ehrhart, Don I. Jung, Amy E. Randel, Gangaram Singh
2009 Human Resource Management Review  
to marry into traditional households where males are the primary breadwinner.  ...  (3) are the theories interchangeable? and (4) how does looking across the literatures focused on different dimensions of diversity inform us about what is really going on in organizations?  ... 
doi:10.1016/j.hrmr.2008.10.004 fatcat:fsudzc4xxbb3holj6xydwryo2e

Understanding diabetic teratogenesis: Where are we now and where are we going?

Sheller Zabihi, Mary R. Loeken
2010 Birth defects research. Clinical and molecular teratology  
In 1936 Pricilla White wrote, "Congenital defects [including heart defects, gastrointestinal atresia, microcephaly, and achondroplasia] are beyond our therapeutic control and are, we believe, related to  ...  Recognizing that cardiac neural crest cells express Pax3, and that cardiac neural crest cell migration and outflow tract septation are defective in Pax3 Sp/Sp embryos, we tested whether COTDs in embryos  ... 
doi:10.1002/bdra.20704 pmid:20706996 pmcid:PMC5070114 fatcat:elbxw724rvfsxhjo23d7j6v2iu

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?

Brian J. Cole, Shane T. Seroyer, Giuseppe Filardo, Sarvottam Bajaj, Lisa A. Fortier
2010 Sports Health A Multidisciplinary Approach  
Despite the promising results of several animal studies, well-controlled human studies are lacking.  ...  Although the fascination with this emerging technology has led to a dramatic increase in its use, scientific data supporting this use are still in their infancy.  ...  Are We Now and Where Are We Going?  ... 
doi:10.1177/1941738110366385 pmid:23015939 pmcid:PMC3445108 fatcat:f56bmsba7bgvbmy2pnyyx5ioue
« Previous Showing results 1 — 15 out of 4,453,688 results